LIQUIDIA CORPORATION - COMMON STOCK

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

08 May 2025 05:30:00 By Nasdaq GlobeNewswire

Liquidia Corporation to Present at BofA Securities 2025 Health Care Conference

06 May 2025 07:00:00 By Nasdaq GlobeNewswire

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

02 May 2025 16:28:34 By Nasdaq GlobeNewswire

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

01 May 2025 07:00:00 By Nasdaq GlobeNewswire

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

01 Apr 2025 09:33:25 By Nasdaq GlobeNewswire

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

01 Apr 2025 07:00:00 By Nasdaq GlobeNewswire

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

28 Mar 2025 08:30:49 By Nasdaq GlobeNewswire

Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference

27 Mar 2025 07:00:00 By Nasdaq GlobeNewswire

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

19 Mar 2025 05:30:00 By Nasdaq GlobeNewswire

Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million

18 Mar 2025 07:00:00 By Nasdaq GlobeNewswire

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

12 Mar 2025 07:00:00 By Nasdaq GlobeNewswire

Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference

08 Jan 2025 07:00:00 By Nasdaq GlobeNewswire

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

13 Nov 2024 05:30:00 By Nasdaq GlobeNewswire

Liquidia to Present at the Stifel 2024 Healthcare Conference

12 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024

06 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024

04 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent

07 Oct 2024 09:00:07 By Nasdaq GlobeNewswire

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

02 Oct 2024 05:00:00 By Nasdaq GlobeNewswire

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

30 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

16 Sep 2024 08:41:30 By Nasdaq GlobeNewswire